Update on cancer-preventive therapeutics.
Brenner
Dean E
DE
Department of Internal Medicine, University of Michigan Medical School, USA.
D018256:Adenomatous Polyps / Q000188:drug therapy; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D016588:Anticarcinogenic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015415:Biomarkers; D001943:Breast Neoplasms / Q000517:prevention & control; D002278:Carcinoma in Situ / Q000175:diagnosis / Q000188:drug therapy; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000517:prevention & control; D003111:Colonic Polyps / Q000188:drug therapy; D004032:Diet; D018450:Disease Progression; D005260:Female; D005544:Forecasting; D020022:Genetic Predisposition to Disease; D006239:Haplotypes; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000235:genetics / Q000517:prevention & control*; D009386:Neoplastic Syndromes, Hereditary / Q000188:drug therapy / Q000235:genetics; D020641:Polymorphism, Single Nucleotide; D055502:Secondary Prevention
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016588:Anticarcinogenic Agents; D015415:Biomarkers